Retatrutide is a groundbreaking therapy generating significant buzz in the weight management field. This unique peptide, developed by Eli Lilly, functions as a combined GIP and GLP-1 target agonist. Essentially, it replicates the action of these natural hormones, which control appetite and encourage feelings of fullness. Clinical trials have sho… Read More